Regulation & Compliance

MEXC's new 'Combo' feature allows traders to bundle up to 20 predictions into a single bet. Is it a revolutionary step or a high-stakes gamble?

A new platform, Claimio, is leveraging automation to overhaul the archaic unclaimed property industry, aiming to reunite Americans with their lost money.

Segal Marco Advisors' move to a co-presidency is more than succession. It's a calculated strategy to master industry complexity and fortify its client-first ethos.

PubMatic, Havas, and Telefónica just proved agentic AI isn't a future concept. It’s here, and it's delivering an 18% cost reduction on CTV ads today.

Virginia American Water's new $16M rate increase funds crucial system upgrades. We explore the balance between customer affordability and the high cost of reliable water.

NetVendor unveils five AI tools to automate vendor compliance. But can its integrated platform overcome implementation hurdles to truly transform proptech?

A new biologic, Nucala, gains Health Canada approval for a specific type of COPD, offering hope for patients and a new strategic frontier for GSK.

A survey reveals 75% of lab researchers prioritize peptide quality over price, a clear signal against the backdrop of a scientific reproducibility crisis.

A new collaboration with Netherlands-based Courdid BV shows Andersen Global isn't just expanding, but strategically targeting the complex world of expatriate services.

Helient's new AI-powered Network as a Service, built on Extreme's platform, signals a major shift from hardware ownership to flexible subscriptions.

A new partnership between Biocartis and City of Hope seeks to transform pancreatic cancer outcomes by pairing breakthrough biomarkers with rapid diagnostic technology.

A new partnership brings instant $50,000 credit lines to cruise ship jewelry stores, blurring the line between vacation bliss and high-stakes finance.

Salesforce's new autonomous 'Agentforce' promises a revolution in digital labor, but how do you govern an AI that thinks for itself? A new DevOps model emerges.

Enveric Biosciences heads to a key UBS investor day to pitch its non-hallucinogenic antidepressant, EB-003. Can it secure the capital needed to revolutionize CNS?

Exavalu's new ExAite platform uses 'agentic AI' to automate software testing, promising huge cost savings and faster releases for the insurance sector.

A new firm, LinkConnect Innovations, has acquired 1,000+ Nokia patents. Backed by global financiers, it promises a 'reasonable' approach to licensing.

A health tech firm's new security certification is more than a press release. It's a blueprint for protecting our most vulnerable in a digital age.

While revenues climb, Nathan's Famous faces a profit squeeze from soaring beef costs and a delayed $450M acquisition by Smithfield Foods due to regulatory review.

Alumni Ventures, a top US firm, launches a London office and a new Global Alumni Syndicate, aiming to reshape VC access for international investors.

With 91% of people lacking financial advice, Plum's new AI tool promises a free, personalized plan. But can a chatbot truly manage your future? I crunched the numbers.